Dopamine Plasma Membrane Transport Proteins
"Dopamine Plasma Membrane Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
| Descriptor ID |
D050483
|
| MeSH Number(s) |
D12.776.157.530.450.625.124 D12.776.157.530.562.374.500.500 D12.776.157.530.937.500 D12.776.543.585.450.625.124 D12.776.543.585.562.374.500.500 D12.776.543.585.937.500
|
| Concept/Terms |
Dopamine Plasma Membrane Transport Proteins- Dopamine Plasma Membrane Transport Proteins
- Dopamine Transporter
- Transporter, Dopamine
- SLC6A3 Protein
- Protein, SLC6A3
- Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein
- Dopamine Transporter Proteins
- Transporter Proteins, Dopamine
- Dopamine Carriers
- Carriers, Dopamine
- DAT Dopamine Transporter Proteins
- Neurotransmitter Transport Proteins, Dopamine-Specific
- Neurotransmitter Transport Proteins, Dopamine Specific
- Neurotransmitter Transporters, Dopamine-Specific
- Dopamine-Specific Neurotransmitter Transporters
- Neurotransmitter Transporters, Dopamine Specific
- Transporters, Dopamine-Specific Neurotransmitter
- DAT Dopamine Transporter
- Dopamine Transporter, DAT
- Transporter, DAT Dopamine
- Dopamine Plasma Membrane Transporter Proteins
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Plasma Membrane Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Plasma Membrane Transport Proteins".
This graph shows the total number of publications written about "Dopamine Plasma Membrane Transport Proteins" by people in this website by year, and whether "Dopamine Plasma Membrane Transport Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 2 | 3 |
| 2007 | 3 | 2 | 5 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 2 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Plasma Membrane Transport Proteins" by people in Profiles.
-
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855.
-
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PLoS One. 2022; 17(9):e0275182.
-
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939.
-
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial. Pharmacogenomics J. 2022 02; 22(1):1-8.
-
Dopamine transporter (DAT1) gene in combat veterans with PTSD: A case-control study. Psychiatry Res. 2021 04; 298:113801.
-
Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport. J Neuroimmune Pharmacol. 2021 12; 16(4):854-869.
-
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2020 10; 44(10):2084-2096.
-
Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport. Sci Rep. 2019 03 07; 9(1):3843.
-
The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 09; 24(5):1109-1118.
-
A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Mol Psychiatry. 2020 09; 25(9):2101-2118.